Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1994 Dec;84(12):1997–2000. doi: 10.2105/ajph.84.12.1997

Changes in insurance status and access to care for persons with AIDS in the Boston Health Study.

J S Weissman 1, H J Makadon 1, G R Seage 3rd 1, M P Massagli 1, C A Gatsonis 1, D E Craven 1, V E Stone 1, I A Bennett 1, A M Epstein 1
PMCID: PMC1615398  PMID: 7998646

Abstract

The purpose of this study was to measure unmet needs and changes in insurance status for persons with acquired immunodeficiency syndrome (AIDS). Thirty-six percent of the study's Boston-area respondents (n = 305) had a change in insurance coverage between AIDS diagnosis and interview. Medicaid coverage increased from 14% to 41%. Pneumocystis carinii pneumonia prophylaxis was nearly universal. Only 5% did not receive zidovudine, and intravenous drug users were at higher risk. Approximately 14% to 15% of patients reported problems in obtaining medical and dental services; Blacks, homeless persons, and those who were not high school graduates were at higher risk. Use of selected treatments for which there were clear clinical guidelines was adequate, yet disadvantaged groups were more likely than other persons with AIDS to face obstacles to other services.

Full text

PDF
1997

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agresti A. Tutorial on modeling ordered categorical response data. Psychol Bull. 1989 Mar;105(2):290–301. doi: 10.1037/0033-2909.105.2.290. [DOI] [PubMed] [Google Scholar]
  2. Anastos K., Marte C. Women--the missing persons in the AIDS epidemic. Health PAC Bull. 1989 Winter;19(4):6–13. [PubMed] [Google Scholar]
  3. Andrulis D. P., Weslowski V. B., Gage L. S. The 1987 US hospital AIDS survey. JAMA. 1989 Aug 11;262(6):784–794. [PubMed] [Google Scholar]
  4. Baily M. A., Bilheimer L., Wooldridge J., Langwell K., Greenberg W. Economic consequences for Medicaid of human immunodeficiency virus infection. Health Care Financ Rev. 1990 Dec;Spec No:97–108. [PMC free article] [PubMed] [Google Scholar]
  5. Campbell C. A. Women and AIDS. Soc Sci Med. 1990;30(4):407–415. doi: 10.1016/0277-9536(90)90343-q. [DOI] [PubMed] [Google Scholar]
  6. Easterbrook P. J., Keruly J. C., Creagh-Kirk T., Richman D. D., Chaisson R. E., Moore R. D. Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group. JAMA. 1991 Nov 20;266(19):2713–2718. [PubMed] [Google Scholar]
  7. Fischl M. A., Richman D. D., Grieco M. H., Gottlieb M. S., Volberding P. A., Laskin O. L., Leedom J. M., Groopman J. E., Mildvan D., Schooley R. T. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987 Jul 23;317(4):185–191. doi: 10.1056/NEJM198707233170401. [DOI] [PubMed] [Google Scholar]
  8. Fowler F. J., Jr, Massagli M. P., Weissman J., Seage G. R., 3rd, Cleary P. D., Epstein A. Some methodological lessons for surveys of persons with AIDS. Med Care. 1992 Nov;30(11):1059–1066. doi: 10.1097/00005650-199211000-00009. [DOI] [PubMed] [Google Scholar]
  9. Green J., Arno P. S. The 'Medicaidization' of AIDS. Trends in the financing of HIV-related medical care. JAMA. 1990 Sep 12;264(10):1261–1266. doi: 10.1001/jama.264.10.1261. [DOI] [PubMed] [Google Scholar]
  10. Hirschel B., Lazzarin A., Chopard P., Opravil M., Furrer H. J., Rüttimann S., Vernazza P., Chave J. P., Ancarani F., Gabriel V. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med. 1991 Apr 18;324(16):1079–1083. doi: 10.1056/NEJM199104183241602. [DOI] [PubMed] [Google Scholar]
  11. Kass N. E., Faden R. R., Fox R., Dudley J. Loss of private health insurance among homosexual men with AIDS. Inquiry. 1991 Fall;28(3):249–254. [PubMed] [Google Scholar]
  12. Moore R. D., Hidalgo J., Sugland B. W., Chaisson R. E. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med. 1991 May 16;324(20):1412–1416. doi: 10.1056/NEJM199105163242006. [DOI] [PubMed] [Google Scholar]
  13. Stein M. D., Piette J., Mor V., Wachtel T. J., Fleishman J., Mayer K. H., Carpenter C. C. Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons. J Gen Intern Med. 1991 Jan-Feb;6(1):35–40. doi: 10.1007/BF02599388. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES